Skin manifestations in patients with malignant hematology diseases;Manifestations cutanees associees aux hemopathies malignes

Presse Medicale

Volumn 26, Issue 14, 1997, Pages 678-683

  Aractingi, S ^a   Mansouri, S ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE;

CLINICAL FEATURE; CLINICAL PRACTICE; HEMATOLOGIC DISEASE; HUMAN; REVIEW; SKIN BIOPSY; SKIN DEFECT; SKIN INFECTION; DRUG ERUPTION; SKIN DISEASE; VASCULITIS;

DRUG ERUPTIONS; HEMATOLOGIC DISEASES; HUMANS; SKIN DISEASES; SKIN DISEASES, INFECTIOUS; VASCULITIS;

EID: 0030947574     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Sepp N, Radaszkiewicz T, Meijer CJLM, Smolle J, Sewann H, Fritsch P. Specific skin manifestations in acute leukemia with monocytic differentiation. A morphologic and immunohistochemical study of 11 cases. Cancer 1993 ; 71:124-32.
2. Ochonisky S, Aractingi S, Dombret H, Verola L, Degos L, Dubertret L. Acute undifferentiated myeloblastic leukemia revealed by bullous and necrotic lesions. Arch Dermatol 1993 ; 129:512-13.
3. Longacre TA, Smoller BR. Leukemia cutis. Analysis of 50 biopsy-proven cases with an emphasis on occurence in myelodysplastic syndromes. Am J Clin Pathol 1993 ; 100:276-84.
4. Aractingi S, Bachmeyer C, Verola O et al. Misleading specific cutaneous lesions in myelodysplasic syndromes. J Am Acad Dermatol 1995 ; 33:187-191.
5. Aractingi S, Janin-Mercier A, Zini JM et al. Mucosal erosions in hypereosinophilic syndrome: evidence for eosinophilic protein deposition. Arch Dermatol 1996 ; 132:535-41.
6. Matloff RB, Neiman RS. Angioimmunoblastic lymphadenopathy. A generalized lymphoproliferative disorder with cutaneous manifestations. Arch Dermatol 1978 ; 114:92-4.
7. Su WPD, Buechner SA, Li CY. Clinicopathologic correlations in leukemia cutis. J Am Acad Dermatol 1984 ; 11:121-28.
8. Shaikh BS, Frantz E, Lookingbill DP. Histologically proven leukemia cutis carries a poor prognosis in acute nonlymphocytic leukemia. Cutis 1987 ; 39:57-60.
9. Cohen P, Kurzrock R. Sweet's Syndrome and malignancy. Am J Med 1987 ; 82:1220-6.
10. Park JW, Mehrotra B, Barnett BO. The Sweet syndrome during therapy with G-CSF. Ann Int Med 1992 ; 116:996-8.
11. Aractingi S, Mallet V, Pinquier L, Vignon-Pennamen D, Chosidow O, Dombret H. Neutrophilic dermatoses during granulocytopenia. Arch Dermatol 1995 ; 131:1141-7.
12. Aractingi S, Bachmeyer C, Dombret M, Verole O, Vignon-Pennamen MD, Dubertret L. Concomittent ocurence of 2 rare cutaneous markers of bad prognosis in oral ELD and specific lesions. Br J Dermatol 1994 ; 131:112-7.
13. Perry H, Winkelman RD. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol 1972 ; 106:901-5.
14. Frankel DH, Larson JA, Lorincz AL. Acral lividiosis. A sign of myeloproliferative diseases. Arch Dermatol 1987 ; 123:921-4.
15. Greer JM, Longley S, Edwards NL, Elfenbein GJ, Panush RS. Vasculitis associated with malignancy. Experience with 13 patients and literature review. Medicine 1988 ; 67:220-30.
16. Farcet JP, Weschsler, J, Wirquin V, Divine M, Reyes F. Vasculitis in hairy-cell leukemia. Arch Intern Med 1987 ; 147:660-4.
17. Anhalt G, Kim S, Stanley JR. Paraneoplastic pemphigus. An autoimmune cutaneous disease associated with neoplasia. N Engl J Med 1990 ; 323:1729-35.
18. Breatnach SM, Black MM. Systemic amyloidosis and the skin: a review with special emphasis on clinical features and therapy. Clin Exp Dermatol 1979 ; 4:517-36.
19. Libbey CA, Skinner M, Cohen AS. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Arch Intern Med 1983 ; 143:1549-53.
20. Kodama H, Nakagawa S, Tanioku K. Plane xanthomatosis with antilipoprotein antibofy. Arch Dermatol 1972 ; 105:722-7.
21. Schnitzler L, Huriez D, Verret JL. Urticaire chronique -ostéocondensation -macroglobulinémie. Cas princeps. Etude sur 20 ans. Ann Dermatol Venereol 1989 ; 116:547-50.
22. Cvhi KH, Chen CH, Chan WK et al. Effect of GM-CSF on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil and leucovorin chemotherapy. J Clin Oncol 1995 ; 13:2620-8.
23. Baack BR, Burgdorf WHC. Chemotherapy-induced aeral eryhtema. J Am Acad Dermatol 1991 ; 24:457-1.
24. Wofson JS, Sober AJ, Rubin RH. Dermatologic manifestations of infections in immunocompromised patients. Medicine 1985 ; 64:115-32.
25. Gorensek MJ. The immunocompromised host. Dermatol Clin 1989 ; 7:353-67.